European vs. Egyptian HCV-4 Patients with Elevated Baseline HCV RNA, Treated with PEG-IFN-α2a and Ribavirin: The Role of Rapid and Early Virologic Response

Dimitrios Dimitroulopoulos; Ioannis Elefsiniotis; Christos Pavlidis; Dimitrios Xinopoulos; Klisthenis Tsamakidis; Stamatina Patsavela; Dimitrios Kypreos; Ageliki Ferderigou; Dimitrios Korkolis; Sotirios Koutsounas; Georgios Saroglou; Emmanouil Paraskevas

Sign in

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

e-ISSN 1735-3408

p-ISSN 1735-143X

Outline

References
Copyright

European vs. Egyptian HCV-4 Patients with Elevated Baseline HCV RNA, Treated with PEG-IFN-α2a and Ribavirin: The Role of Rapid and Early Virologic Response

Authors

Dimitrios Dimitroulopoulos^1,*, Ioannis Elefsiniotis², Christos Pavlidis³, Dimitrios Xinopoulos¹, Klisthenis Tsamakidis¹, Stamatina Patsavela¹, Dimitrios Kypreos¹, Ageliki Ferderigou⁴, Dimitrios Korkolis⁵, Sotirios Koutsounas⁶, Georgios Saroglou⁷, Emmanouil Paraskevas⁸

1Department of Gastroenterology, Agios Savvas Hospital, Athens, Greece

2Department of Internal Medicine, Helena Venizelou Hospital–University of Athens, Athens, Greece

3Reference Center for Viral Hepatitis,IKA, Athens, Athens, Greece

4Department of Biochemistry, Agios Savvas Hospital, Athens, Greece

5First Surgical Department, Agios Savvas Hospital, Athens, Greece

6Reference Center for Viral Hepatitis, IKA, Athens, Greece

7Department of Internal Medicine, Helena Venizelou Hospital – University of Athens, Athens, Greece

8Department of Gastroenterology,Agios SavvasHospital, Athens, Greece

*Corresponding Author: Department of Gastroenterology, Agios Savvas Hospital, Athens, Greece Email: [email protected]

Hepatitis Monthly:Vol. 10, issue 3; e92981

Published online:Jun 30, 2010

Article type:Research Article

Received:May 05, 2019

Accepted:Jun 30, 2010

How to Cite:Dimitroulopoulos D, Elefsiniotis I, Pavlidis C, Xinopoulos D, Tsamakidis K, et al. European vs. Egyptian HCV-4 Patients with Elevated Baseline HCV RNA, Treated with PEG-IFN-α2a and Ribavirin: The Role of Rapid and Early Virologic Response. Hepat Mon. 2010;10(3):e92981. doi:

KeywordsHCV Genotype 4 EVR RVR Treatment

References

1.
The references are available in the PDF file.

Copyright

© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

1

Jan

2015

Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1

Heidar Sharafi,

Seyed Moayed Alavian,

Maryam Keshvari

PDF

Sharafi H, Alavian SM, Keshvari M. Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1. Hepat Mon. 2015;15(1):e24955. doi: https://doi.org/10.5812/hepatmon.24955

31

Dec

2008

Optimizing Treatment with Pegylated Interferon-Ribavirin of Genotype 3 Chronic Hepatitis C: More Questions than Answers

Alessio Aghemo,

Roberta D'Ambrosio,

Maria Grazia Rumi,

Massimo Colombo

PDF

Aghemo A, D'Ambrosio R, Rumi M, Colombo M. Optimizing Treatment with Pegylated Interferon-Ribavirin of Genotype 3 Chronic Hepatitis C: More Questions than Answers. Hepat Mon. 2008;8(4):. doi:

14

Dec

2013

Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin

Zaigham Abbas,

Ghiasun Nabi Tayyab,

Mustafa Qureshi,

Mohammad Sadik Memon,

Amna Subhan,

Tanzila Shakir

,et al.

PDF

Abbas Z, Tayyab GN, Qureshi M, Memon MS, Subhan A, et al. Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin. Hepat Mon. 2013;13(12):e14146. doi: https://doi.org/10.5812/hepatmon.14146

27

May

2013

The Effect of Peginterferon Alpha-2a vs. Peginterferon Alpha-2b in Treatment of Naive Chronic HCV Genotype-4 Patients: A Single Centre Egyptian Study

Maissa El Raziky,

Waleed Fouad Fathalah,

Wafaa Ahmed El-akel,

Ahmed Salama,

Gamal Esmat,

Mahassen Mabrouk

,et al.

PDF

El Raziky M, Fathalah WF, El-akel WA, Salama A, Esmat G, et al. The Effect of Peginterferon Alpha-2a vs. Peginterferon Alpha-2b in Treatment of Naive Chronic HCV Genotype-4 Patients: A Single Centre Egyptian Study. Hepat Mon. 2013;13(5):10069. doi: https://doi.org/10.5812/hepatmon.10069

23

Jun

2015

Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective Study

Alessandro Federico,

Mario Masarone,

Marco Romano,

Marcello Dallio,

Valerio Rosato,

Marcello Persico

PDF

Federico A, Masarone M, Romano M, Dallio M, Rosato V, et al. Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective Study. Hepat Mon. 2015;15(6):e18640. doi: https://doi.org/10.5812/hepatmon.15(6)2015.18640

More by these authors

Dimitrios DimitroulopoulosPubMed Scholar

Ioannis ElefsiniotisPubMed Scholar

Christos PavlidisPubMed Scholar

Dimitrios XinopoulosPubMed Scholar

Klisthenis TsamakidisPubMed Scholar

Stamatina PatsavelaPubMed Scholar

Dimitrios KypreosPubMed Scholar

Ageliki FerderigouPubMed Scholar

Dimitrios KorkolisPubMed Scholar

Sotirios KoutsounasPubMed Scholar

Georgios SaroglouPubMed Scholar

Emmanouil ParaskevasPubMed Scholar

Find related work

PubMed

Google Scholar

Create citation alert

Download PDF480.03 KB

Import into EndNote Import into BibTex

Share

Cited by

Scopus by DOI: 0
Last Update: 1 day ago
Scopus by Title: 8
Last Update: 1 day ago
Scopus by Title (Ref): 8
Last Update: 1 day ago
CrossRef: 0
Last Update: 6 days ago

Metrics

Comments

Number of Comments:0